Following the first demonstration of the role of miRNAs in chronic lymphocytic leukemia [3], a large number of reports of dysregulated miRNAs associated with diseases such as cancer [4], diabetes [5] and cardiovascular disease [6] have emerged.
With the first demonstration of the role of miRNAs in chronic lymphocytic leukemia, [3] has been reported by a large number of miRNAs related to disease disorders, such as cancer [4], diabetes [5] and cardiovascular disease [6].
With the first demonstration of the role of miRNAs in chronic lymphoblastic leukemia [3], a large number of miRNAs with disease-related disorders have been reported, such as cancer [4], diabetes [5] and cardiovascular diseases [6].